We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NXG market cap is 20.45M. The company's latest EPS is CAD -0.0047 and P/E is -61.70.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 9.54M | 11.04M | 11.84M | 12.78M | 13.85M |
| Operating Income | 339k | 2.39M | 2.43M | 620k | 209k |
| Net Income | -207k | 2.12M | 4.02M | -22k | -332k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 21.19M | 25.24M | 29.44M | 25.75M | 30.2M |
| Total Liabilities | 19.35M | 19.72M | 19.72M | 16.9M | 22.48M |
| Total Equity | 1.84M | 5.52M | 9.71M | 8.85M | 7.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | 1.05M | 2.65M | 3.83M | 1.07M | 1.28M |
| Investing | -957k | -1.08M | -1.37M | -507k | -248k |
| Financing | -395k | -1.3M | -940k | -1.11M | -919k |
| Market Cap | 20.45M |
| Price to Earnings Ratio | -61.70 |
| Price to Sales Ratio | 1.48 |
| Price to Cash Ratio | 10.9 |
| Price to Book Ratio | 2.65 |
| Dividend Yield | - |
| Shares Outstanding | 70.53M |
| Average Volume (1 week) | 104.5k |
| Average Volume (1 Month) | 38.5k |
| 52 Week Change | -9.38% |
| 52 Week High | 0.32 |
| 52 Week Low | 0.175 |
| Spread (Intraday) | 0.03 (8.62%) |
| Company Name | Nexgenrx Inc |
| Address |
191 the west mall, suite 905 toronto, ontario M9C 5L6 |
| Website | https://www.nexgenrx.com |
| Industry | admin-public health programs (9431) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
